Prevention of heterotopic ossification after total hip replacement with NSAIDs

被引:63
作者
Fijn, R
Koorevaar, RT
Brouwers, JRBJ
机构
[1] Univ Groningen Inst Drug Explorat, Groningen Res Inst Pharm GRIP, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, NL-9713 AV Groningen, Netherlands
[3] W Fries Gasthuis, Dept Clin Pharm, Hoorn, Netherlands
[4] Univ Nijmegen Hosp, Dept Orthopaed, NL-6500 HB Nijmegen, Netherlands
[5] Leeuwarden & Tjongerschans Hosp, Dept Clin Pharmacol, Leeuwarden Med Ctr, Heerenveen, Netherlands
[6] Leeuwarden & Tjongerschans Hosp, Dept Hosp Pharm, Leeuwarden Med Ctr, Heerenveen, Netherlands
来源
PHARMACY WORLD & SCIENCE | 2003年 / 25卷 / 04期
关键词
COX-2; inhibitors; diclofenac; heterotopic ossification (HO); indomethacin; naproxen; non-steroidal; anti-inflammatory drugs (NSAIDs); rofecoxib;
D O I
10.1023/A:1024830213832
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: non steroidal anti-inflammatory drugs ( NSAIDs) and prophylactic radiotherapy can prevent ectopic bone formation around the hip after total hip arthroplasty. Methods: We retrieved from Medline, Embase and the Cochrane Register ( clinical) trials and other relevant literature on the prevention of heterotopic ossification (HO) from 1990-2002 for further review. Results: Review of these clinical trials shows that HO is effectively prevented by a postoperative NSAID treatment with indomethacin for at least seven days. The best evidence is available for indomethacin, although naproxen, diclofenac and ibuprofen are also well documented. Short term use of ibuprofen is not effective. If NSAIDs are contraindicated, preoperative or postoperative radiotherapy is a very effective therapeutic option to prevent HO. Discussion and conclusion: Because of the potential of serious gastrointestinal side effects of NSAIDs and their interaction with anticoagulant drugs, rofecoxib and other COX-2 specific NSAIDs may be a safer option for the treatment of HO. However, randomised controlled studies are needed to confirm the results of the rofecoxib study.
引用
收藏
页码:138 / 145
页数:8
相关论文
共 50 条
  • [21] Prevention of heterotopic ossification in hip arthroplasty The influence of the duration of treatment
    L. Vastel
    L. Kerboull
    O. Dejean
    J.-P. Courpied
    M. Kerboull
    International Orthopaedics, 1999, 23 : 107 - 110
  • [22] Is Heterotopic Ossification Associated With Surgical Approach in Total Hip Arthroplasty?
    Wilke, Benjamin K.
    Guier, Christian
    Applewhite, Andres
    Garner, Hillary W.
    Stanborough, Rupert O.
    Spaulding, Aaron
    Sebro, Ronnie A.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2023, 31 (07) : E385 - E393
  • [23] Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review
    Haffer, Henryk
    Mueller, Michael
    Ascherl, Rudolf
    Perka, Carsten
    Winkler, Tobias
    HIP INTERNATIONAL, 2022, 32 (02) : 144 - 151
  • [24] Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin?
    Vasileiadis, G. I.
    Sakellariou, V. I.
    Kelekis, A.
    Galanos, A.
    Soucacos, P. N.
    Papagelopoulos, P. J.
    Babis, G. C.
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2010, 10 (02) : 159 - 165
  • [25] Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis
    Ma, Ran
    Chen, Guan-Hong
    Zhao, Liu-Jing
    Zhai, Xi-Cheng
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2018, 13
  • [26] Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis
    Ran Ma
    Guan-Hong Chen
    Liu-Jing Zhao
    Xi-Cheng Zhai
    Journal of Orthopaedic Surgery and Research, 13
  • [27] A systematic review and meta-analysis of naproxen for prevention heterotopic ossification after hip surgery
    Zhang, Ai-Hua
    Chen, Xiang
    Zhao, Qing-Xia
    Wang, Ke-Lai
    MEDICINE, 2019, 98 (14)
  • [28] Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty
    van der Heide, HJL
    Koorevaar, RT
    Schreurs, BW
    van Kampen, A
    Lemmens, A
    JOURNAL OF ARTHROPLASTY, 1999, 14 (07) : 796 - 799
  • [29] Heterotopic Ossification in Hip Arthroscopy
    Seijas, Roberto
    Barastegui, David
    Celis, Carlos Lopez de
    Montana, Ferran
    Cusco, Xavier
    Cugat, Ramon
    SURGERY JOURNAL, 2023, 09 (01) : E8 - E12
  • [30] COX-2 Inhibitors for the Prevention of Heterotopic Ossification After THA
    Vasileiadis, George I.
    Sioutis, Ioannis C.
    Mavrogenis, Andreas F.
    Vlasis, Konstantinos
    Babis, George C.
    Papagelopoulos, Panayiotis J.
    ORTHOPEDICS, 2011, 34 (06) : 467 - 472